A double-blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia Who Have Undergone a Kasi Hepatoportoenterostomy

Administered By

Awarded By

Contributors

Start/End

  • March 14, 2022 - March 2, 2024